Reuters logo
BRIEF-Zhongyuan Union Cell and Gene Engineering unit to sell 38 pct stake in Tianjin Amcellgene Engineering Co Ltd at 45 mln yuan
December 27, 2016 / 9:32 AM / 10 months ago

BRIEF-Zhongyuan Union Cell and Gene Engineering unit to sell 38 pct stake in Tianjin Amcellgene Engineering Co Ltd at 45 mln yuan

Dec 27 (Reuters) - Zhongyuan Union Cell and Gene Engineering :

* Says its subsidiary Union Stemcell & Gene Engineering Co Ltd will sell 38 percent stake in Tianjin Amcellgene Engineering Co Ltd to a Beijing-based biotechnology company

* Says Union Stemcell & Gene Engineering Co Ltd holds 38 percent stake in Tianjin Amcellgene Engineering Co Ltd now

Source text in Chinese: goo.gl/Ig5ifH

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below